DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of…
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of…